Prostate Cancer Canada encouraged by growing political support for PSA test coverage in BC



Vancouver BC - April 11, 2017 - Prostate Cancer Canada (PCC) applauds the first provincial party in BC to announce their commitment to cover the cost of PSA (prostate-specific antigen) tests for men when ordered by a physician. With the BC Liberals having made their intention official as part of the campaign platform today, PCC encourages the provincial NDP and Green parties to follow suit with their support of this important initiative.

Prostate cancer is the most common cancer in Canadian men; 1 in 7 will be diagnosed in their lifetime. When detected early, the survival rate for prostate cancer can be over 90%. Once the cancer has spread beyond the prostate, however, survival at five years drops to 31 per cent. In 2016, an estimated 560 men lost their lives to prostate cancer in BC alone.

The PSA test is the best available screening tool to alert doctors to a potential problem prior to the onset of symptoms that are generally associated with cancer spread. Currently, 8 of 10 provinces cover the cost of PSA testing for asymptomatic men when ordered by their doctor.

“Together with survivors, caregivers, and clinicians from across BC, we have worked closely with officials across partisan lines for some time to help educate regarding the importance of including PSA testing in public healthcare coverage from both health and economic perspectives,” explained Dr. Stuart Edmonds, PCC’s Vice-President of Research, Survivorship and Health Promotion. “With today’s platform announcement, the BC Liberals have demonstrated a strong commitment to men and their families throughout the province. We are confident that the NDP and Green parties will do the same.”

In the last 15 years, Prostate Cancer Canada has invested over $20 million in research and survivorship initiatives in British Columbia.

-30-

About Prostate Cancer Canada
Prostate Cancer Canada is the leading national foundation dedicated to the elimination of the most common cancer in men through research, advocacy, education, support and awareness. As one of the largest investors in prostate cancer research in Canada, Prostate Cancer Canada is committed to continuous discovery in the areas of prevention, diagnosis, treatment, and support. Learn more at www.prostatecancer.ca

For more information:
Adam Milller
Prostate Cancer Canada
416-441-2131 ext. 235
adam.miller@prostatecancer.ca



Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive